2. Academic Validation
  3. Functional Metabolomics Characterizes a Key Role for N-Acetylneuraminic Acid in Coronary Artery Diseases

Functional Metabolomics Characterizes a Key Role for N-Acetylneuraminic Acid in Coronary Artery Diseases

  • Circulation. 2018 Mar 27;137(13):1374-1390. doi: 10.1161/CIRCULATIONAHA.117.031139.
Lei Zhang 1,  Ting-Ting Wei 1,  Yong Li 2,  Jing Li 3,  Yong Fan 1,  Feng-Qing Huang 1,  Yuan-Yuan Cai 3,  Gaoxiang Ma 3,  Jin-Feng Liu 1,  Qian-Qian Chen 1,  Shi-Lei Wang 1,  Honglin Li 4,  Raphael N Alolga 1,  Baolin Liu 3,  Dong-Sheng Zhao 5,  Jian-Hua Shen 6,  Xiang-Ming Wang 7,  Wei Zhu 8,  Ping Li 9,  Lian-Wen Qi 9 3
Affiliations

Affiliations

  • 1 State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing (L.Z., T.-T.W., Y.F., F.-Q.H., J.-F.L., Q.-Q.C., S.-L.W., R.N.A., P.L., L.-W.Q.).
  • 2 Department of Cardiology, the Affiliated Wujin Hospital of Jiangsu University, Changzhou, China (Y.L.).
  • 3 Clinical Metabolomics Center, China Pharmaceutical University, Nanjing (J.L., Y.-Y.C., G.M., B.L., L.-W.Q.).
  • 4 Shanghai Key Laboratory of New Drug Design, State Key Laboratory of Bioreactor Engineering, School of Pharmacy, East China University of Science and Technology (H.L.).
  • 5 Department of Cardiology, Second Affiliated Hospital of Nantong University, Nantong (D.-S.Z.).
  • 6 Department of Cardiology, Northern Jiangsu People's Hospital, Yangzhou, China (J.-H.S.).
  • 7 Department of Geriatric Cardiology (X.-M.W.).
  • 8 Department of Oncology (W.Z.), First Affiliated Hospital of Nanjing Medical University, China liping2004@126.com Qilw@cpu.edu.cn zhuwei@njmu.edu.cn.
  • 9 State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing (L.Z., T.-T.W., Y.F., F.-Q.H., J.-F.L., Q.-Q.C., S.-L.W., R.N.A., P.L., L.-W.Q.) liping2004@126.com Qilw@cpu.edu.cn zhuwei@njmu.edu.cn.
PMID: 29212895 DOI: 10.1161/CIRCULATIONAHA.117.031139
Abstract

Background: As new biomarkers of coronary artery diseases (CAD) emerge via metabolomics, the underlying functional mechanisms remain to be elucidated. Functional metabolomics aims to translate metabolomics-derived biomarkers to disease mechanisms.

Methods: A cohort of 2324 patients who underwent coronary angiography from 4 independent centers was studied. A combination of ultra-performance liquid chromatography and quadrupole time-of-flight mass spectrometry in the negative ion mode was used for untargeted analysis of metabolites in plasma. Significant differential metabolites were identified by cross-comparisons with and within CAD types, including normal coronary artery, nonobstructvie coronary atherosclerosis, stable angina, unstable angina, and acute myocardial infarction. A tandem liquid chromatography-mass spectrometry-based approach using isotope-labeled standard addition was subsequently performed for targeted analysis of the metabolic marker N-acetylneuraminic acid (Neu5Ac). A functional metabolomics strategy was proposed to investigate the role of Neu5Ac in the progression of CAD by using in vitro and in vivo models.

Results: We identified a total of 36 differential metabolites, 35 of which were confirmed with reference compounds. Elevation of Neu5Ac was observed in plasma during CAD progression in center 1 (P=4.0e-64, n=2019) and replicated in 3 independent centers (n=305). The increased level of Neu5Ac in plasma was confirmed by accurate targeted quantification. Mechanistically, Neu5Ac was able to trigger myocardial injury in vitro and in vivo by activation of the Rho/Rho-associated coiled-coil containing protein kinase signaling pathway through binding to RhoA and Cdc42, but not Rac1. Silencing neuraminidase-1, the Enzyme that regulates Neu5Ac generation, ameliorated oxygen-glucose deprivation-induced injury in cardiomyocytes and ligation/isoprenaline-induced myocardial ischemia injury in rats. Pharmacological inhibition of neuraminidase by anti-influenza drugs, oseltamivir and zanamivir, also protected cardiomyocytes and the heart from myocardial injury.

Conclusions: Functional metabolomics identified a key role for Neu5Ac in acute myocardial infarction, and targeting neuraminidase-1 may represent an unrecognized therapeutic intervention for CAD.

Keywords

biomarkers; cardiovascular diseases; coronary artery disease; metabolomics; myocardial ischemia; neuraminidase.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z